FDG PET/CT Performed Prior to CT-Guided Percutaneous Biopsy of Lung Masses is Associated With an Increased Diagnostic Rate and Often Identifies Alternate Safer Sites to Biopsy
Canadian Association of Radiologists Journal · 2025-08 · 76 (3) · 534-540
DOI: 10.1177/08465371241306731 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Canadian Association of Radiologists Journal, online erschienen am 18.12.2024. Verfasst von Jordan Haidey und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Image-Guided Biopsy, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To determine the benefit of a FDG PET/CT scan prior to CT-guided lung biopsy on the rate of diagnosis, rate of complication, and the identification of potentially safer biopsy sites.
Methods
This retrospective observational cross-sectional study evaluated consecutive adult patients who underwent CT-guided lung biopsy in 2020 or 2021 at 2 Canadian tertiary care hospitals. These patients were grouped into those that had PET/CT performed within 8 weeks prior to biopsy, within 8 weeks after biopsy, or no PET/CT scan within this time frame. Biopsy complication rates and pathology diagnostic rates were compared. The PET/CT images of those performed after biopsy were reviewed to determine if alternate safer biopsy sites could be identified. Categorical variables were compared using Pearson chi square test ( P < .05 significant).
Results
547 patients who had CT-guided lung biopsy were included. Patients with lung masses (≥3 cm) who had a PET/CT scan prior to biopsy had a higher diagnostic rate (90.8%) compared to those that did not (80.2%). The overall post-biopsy pneumothorax rate was 43.3% with 11.3% overall requiring chest tube insertion and 13.9% requiring hospitalization. There was no difference in complication rate for those who had PET/CT prior to biopsy and those that did not. 28.9% to 42.1% of patients who had PET/CT after biopsy had safer sites amenable to biopsy identified retrospectively outside of the lungs.
Conclusion
PET/CT prior to CT-guided lung biopsy improves the diagnostic rate in 10.6% of patients with lung masses (≥3 cm) and identifies alternate safer sites to biopsy in 28.9% to 42.1% of patients (any size lesion).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Alberta, Edmonton, AB, Canada.
- Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.
ORCID-Profile: Jonathan T Abele
Zitieren
APA
Haidey, J., & Abele, J. T. (2025). FDG PET/CT Performed Prior to CT-Guided Percutaneous Biopsy of Lung Masses is Associated With an Increased Diagnostic Rate and Often Identifies Alternate Safer Sites to Biopsy. Canadian Association of Radiologists Journal, 76(3), 534-540. https://doi.org/10.1177/08465371241306731
Vancouver
Haidey J, Abele JT. FDG PET/CT Performed Prior to CT-Guided Percutaneous Biopsy of Lung Masses is Associated With an Increased Diagnostic Rate and Often Identifies Alternate Safer Sites to Biopsy. Canadian Association of Radiologists Journal. 2025;76(3):534-540. doi:10.1177/08465371241306731
BibTeX
@article{Haidey2025,
author = {Haidey, Jordan and Abele, Jonathan T},
title = {FDG PET/CT Performed Prior to CT-Guided Percutaneous Biopsy of Lung Masses is Associated With an Increased Diagnostic Rate and Often Identifies Alternate Safer Sites to Biopsy},
journal = {Canadian Association of Radiologists Journal},
year = {2025},
volume = {76},
number = {3},
pages = {534--540},
doi = {10.1177/08465371241306731}
}
EUVIMED